A detailed history of Alpine Bank Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Alpine Bank Wealth Management holds 1,093 shares of LLY stock, worth $904,501. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,093
Previous 2,712 59.7%
Holding current value
$904,501
Previous $2.4 Billion 62.43%
% of portfolio
0.14%
Previous 0.38%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025

SELL
$725.72 - $929.72 $1.17 Million - $1.51 Million
-1,619 Reduced 59.7%
1,093 $903 Million
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $2.09 Million - $2.6 Million
2,712 New
2,712 $2.4 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $786B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alpine Bank Wealth Management Portfolio

Follow Alpine Bank Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Bank Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Bank Wealth Management with notifications on news.